0001209191-19-041035.txt : 20190703
0001209191-19-041035.hdr.sgml : 20190703
20190703160446
ACCESSION NUMBER: 0001209191-19-041035
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190701
FILED AS OF DATE: 20190703
DATE AS OF CHANGE: 20190703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Aldag Jorn
CENTRAL INDEX KEY: 0001734412
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38443
FILM NUMBER: 19941930
MAIL ADDRESS:
STREET 1: C/O UNUM THERAPEUTICS INC.
STREET 2: 200 CAMBRIDGE PARK DRIVE SUITE 3100
CITY: CAMBRIDGE
STATE: MA
ZIP: 02210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Unum Therapeutics Inc.
CENTRAL INDEX KEY: 0001622229
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 465308248
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 CAMBRIDGE PARK DRIVE
STREET 2: SUITE 3100
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
BUSINESS PHONE: 617-945-5576
MAIL ADDRESS:
STREET 1: 200 CAMBRIDGE PARK DRIVE
STREET 2: SUITE 3100
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
FORMER COMPANY:
FORMER CONFORMED NAME: Unum Therapeutics, Inc.
DATE OF NAME CHANGE: 20141014
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-07-01
0
0001622229
Unum Therapeutics Inc.
UMRX
0001734412
Aldag Jorn
C/O UNUM THERAPEUTICS INC.
200 CAMBRIDGE PARK DRIVE, SUITE 3100
CAMBRIDGE
MA
02140
1
0
0
0
Stock Option (Right to Buy)
2.41
2019-07-01
4
A
0
7608
1.7745
A
2029-07-01
Common Stock
7608
7608
D
The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant.
This option is fully vested at time of grant.
/s/ Amoli Pandya, as Attorney-in-Fact
2019-07-03